BPC-157 + KPV
Gut healing blend · gut-repair stack
ANECDOTAL + ANIMAL STUDIES · CYTOPROTECTIVE PENTADECAPEPTIDE (BPC-157) + ALPHA-MSH-DERIVED TRIPEPTIDE (KPV) BLEND
Mechanism of action
BPC-157 promotes angiogenesis (VEGFR2), stabilises gut barrier function, and accelerates epithelial repair; KPV exerts NF-kB-suppressing anti-inflammatory activity at the colonic mucosa via melanocortin pathway intermediates. Layered: BPC-157 drives repair while KPV damps the inflammatory signal that delays it.
Researched effects
Gut mucosal repair; inflammatory bowel symptom support; intestinal-barrier restoration; combined healing + anti-inflammatory action commonly stacked for leaky-gut/IBD anecdotal protocols
Dosing reported in literature
250-500 mcg BPC-157 + 500-1000 mcg KPV SC daily near area of concern, or oral compounded form 1-2x daily. Cycle 4-6 weeks on / 2-4 weeks off
Known concerns
Both components are research compounds with limited human safety data; injection-site reactions; theoretical immune modulation; not FDA-approved for any indication
No references match — clear filters.
Curated sources on file
3- 1.
- 2.
- 3.